Immuno-oncology

W9 - Glucose Metabolism Controls Human γδ-T Cell-mediated Tumor Immunosurveillance in Diabetes Through AMPK Pathway

Th6 - A CXCR4/PLC-mediated Cell Survival Pathway is Involved in Steroid Resistance of B-acute Lymphoblastic Leukemia

W17 - Immune Remodelling in Advanced Adenocarcinoma by a CD40L-MUC1 Vaccine

W56 - Evaluation of GPER Activation Pathways Associated with Migration and Invasion in LNCaP Cells

W74 - The Tumor Suppressor APC Regulates T Lymphocytes Migration: Insights from Familial Polyposis Patients

Th20 - An Academic BCMA-directed CAR-T Therapy (ARI0002h) with Fractionated and Booster Dose in Patients with Relapsed/Refractory Multiple Myeloma: First Data About Efficacy and Safety

Th32 - A Case of μ Heavy and λ Light Chain Amyloidosis in a Patient with Bi-clonal (IgM κ and λ ) Gammopathy Successfully Treated with Daratumumab

Th34 - Performance Comparison of the Spectral Signature, Spillover Spreading Matrix, and Data Unmixing Quality Between the Spectral Cytek Aurora and the Spectral BD FACS Symphony A5 SE by a 35-Color Human Broad Immunophenotyping Panel

Th42 - Next-generation Immunostimulatory Antibody-drug Conjugate (iADC) Combines Direct Tumor Killing and Innate Immune Stimulation to Provide Protective Anti-Tumor Immunity

Th47 - Single Cell and Spatially Resolved Analysis of Tissues by Integrated RNA and Protein Multi-omics Identifies Novel Tumour-infiltrating Lymphocyte Phenotypes

Th72 - Engineering of Alpha/Beta Selective IL-2 Muteins for Antigen Activated T cells in Solid Tumors

Th80 - The Role of Mucosal-Associated Invariant T (MAIT) Cells in Glioblastoma Immunity

Tu52 - NKG2D Co-stimulation Differentially Reprograms CD8 T Cells for Enhanced Memory Formation and Homeostasis in Mouse Prostate Tumors

Tu74 - CD3+CD56+ Cells in Cervical Cancer Patients: Evaluation of Immune Checkpoint Expression

Tu81 - Multiplexed Single-cell Analysis Reveals Dysfunctional CD8+ CD103+ T Cells and Negatively Prognostic CD38+ Regulatory T Cells in Human Colorectal Cancer

Tu83 - Anti-TIGIT Antibodies Promote Immune Activation in Combination with Immunotherapeutic Agents

Tu86 - Rescuing Antitumor Responses Mediated by Immune Checkpoint Inhibition Through Jak Inhibition

Th111 - Metastatic melanoma (MM) patients with stable disease display reduced Mo-MDSCs levels in peripheral blood

Th142 - Evaluation of the MAPK and PI3K Signaling Pathways in Cancer Stem Cells Isolated from Prostate Cancer Tumor Tissues, a Preliminary Study

Th165 - Induction of a T Cell Intrinsic DNA Damage and Repair Response is Associated with Clinical Response to PD-1 Blockade

Th178 - The CDKN2A Deletion Influences the Establishment of the Tumor Immune Microenvironment of Pancreatic Ductal Adenocarcinoma

Tu120 - Spatial Whole Transcriptome Profiling of the Tumor Microenvironment in FFPE Prostate Carcinoma using the Visium Platform

Tu128 - Enhanced Function of Vaccine Dendritic Cells from Obese Donor upon Inhibition of Lipid Metabolism

Tu141 - Correlation of GPER with GLI1 and GLI3 in Tumor and Stromal Tissue with Different Prognosis Groups of Patients with Prostate Cancer

Tu147 - Regulatory T Cell Functional Dynamics During The Response To PD-1 Blockade

Tu153 - Comprehensive Analysis of the Immune Landscape in the Peripheral Blood of Advanced Melanoma Patients Reveals Chronic Activation of Differentiated Cytolytic Cell Subsets